OMRON Healthcare has received de novo authorization from the U.S. Food and Drug Administration (FDA) to market new home blood pressure monitors featuring AI-powered atrial fibrillation ...
In a pivotal stride to address the growing AFib epidemic, OMRON Healthcare today announced the U.S. Food and Drug ...
Variable Frequency Drive Market Driving Sustainable Growth Through Advanced energy Efficiency and Optimized Industrial Control ...
Omron's resilience through the pandemic was thanks to our mission of empowering health and reducing risk for Filipinos. Our ...
The Technical University of Munich (TUM) is highly regarded by global employers, ranking 13th in the latest Global University ...
(IN BRIEF) Telenor Group has launched its AI Factory, an initiative backed by a 100 million NOK investment to support ...
The FDA has granted a de novo clearance to a wearable device—with a form factor you’re familiar with—that can check patients ...
In a pivotal stride to address the growing AFib epidemic, OMRON Healthcare today announced the U.S. Food and Drug Administration (FDA) has granted the company its De Novo authorization to market new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback